Government, employers and nonprofit organizations are trying to raise awareness about manufacturing jobs — and to combat some negative stereotypes.
Industry
UnitedHealth expects its sales and profit growth to continue into its final quarter as it downsizes its Obamacare plan offerings to three states.
A recent report found that take-home pharmaceuticals experienced the sharpest price increase with a 9.3 percent year-over-year rise.
The early-stage investment has so far raised $20 million of a $30 million funding round, which it plans to distribute to promising tech entrepreneurs.
Latest Articles
The early-stage investment has so far raised $20 million of a $30 million funding round, which it plans to distribute to promising tech entrepreneurs.
Investment firm Onex Corporation appears to be purchasing Save-A-Lot for a bargain as it was previously valued at $1.8 billion.
Chamber president Doug Loon said lawmakers should not be “imposing a straightjacket with one-size-fits-all mandates.”
After studying how customers used its product, St. Louis Park-based Joia took that information and developed a new product that’s attracting deals with the Target Center and even a Vegas hotel chain.
Mike Lister is a former executive and current owner of several Famous Dave's franchise locations.
It’s uncertain how much music is contained within the vault, but those close to Prince believe the number of unreleased tracks to be in the thousands.
Twin Cities business leaders say the region must do a better job of recruiting people to move here — and of keeping them here once they arrive.
Sloan will be taking over the nation’s largest bank amid a storm of controversy, although his 29 years there was spent largely removed from the scandal events.
Calyxt founder Dan Voytas is applying editing methods for non-GMO crop improvements.
The off-road vehicles company hopes its purchase of Transamerican Auto Parts will gain it market share in a more than $10 billion a year Jeep and truck accessory market.
The money will fund research that could potentially improve individualized medicine practices and allow physicians to better select drugs tailored to a patient’s unique tumor.
Recent findings from the Twin Cities campus and the University of Toronto show how targeting specific cells could reveal better treatment plans for a number of deadly diseases.
Same lab recently announced a breakthrough in mouse modeling for ALS research.
Study says consumers pay as much as 13% less for narrow-network plans.
Eagan firm seeks Nasdaq hearing.
MSP Communications, 953 Westgate Drive, Suite 107, St. Paul, MN, 55114 © 2026 Key Enterprises LLC All rights reserved.